Transcription of Medicines Control Council
{{id}} {{{paragraph}}}
Example: barber
Medicines Control Council
Registration of Medicines Reporting of Adverse Drug Reactions Medicines Control Council . REPORTING ADVERSE DRUG REACTIONS. IN SOUTH AFRICA. IMPORTANT NOTE. This guideline applies only to the reporting of SAEs during clinical trials. An update of the guideline for this purpose is being developed. The reporting of post-marketing ADRs is described in guideline REPORTING OF POST-MARKETING ADVERSE DRUG REACTIONS TO HUMAN. MEDICINAL PRODUCTS IN SOUTH AFRICA. This document has been prepared to serve as a guideline to those reporting adverse drug reactions. It represents the Medicines Control Council s current thinking on the safety, quality and efficacy of Medicines .
Registration of Medicines Reporting of Adverse Drug Reactions 2.11_ADR_reporting_May03_v1_2.doc December 2012 Page 1 of 18 MEDICINES CONTROL COUNCIL REPORTING ADVERSE DRUG REACTIONS
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
ICH guideline E2F on development safety update, Development Safety Update Report, Development, ICH E2F – Development SafetyDevelopment Safety Update Report, International Conference on Harmonisation, Procedures for Clinical Trials, Safety, Development Safety Update, DEVELOPMENT SAFETY UPDATE REPORT - ICH, PHARMACEUTICAL, FINISHED PHARMACEUTICAL PRODUCTS, Update, Pharmaceutical ingredients and, Post-marketing Surveillance of Drugs, DEVELOPMENT OF PAEDIATRIC MEDICINES:, Development of paediatric medicines: points to consider in pharmaceutical development